Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
Author(s) -
Stefano De Cillà,
Serena Farruggio,
Stela Vujosevic,
Giulia Raina,
Davide Filippini,
Valentina Gatti,
Nausicaa Clemente,
David Mary,
Diego Vezzola,
Giamberto Casini,
Luca Rossetti,
Elena Grossini
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000479441
Subject(s) - retinal pigment epithelium , occludin , tight junction , microbiology and biotechnology , paracellular transport , epithelium , biology , chemistry , fetal bovine serum , retinal , cell , permeability (electromagnetism) , biochemistry , genetics , membrane
he anti-vascular endothelial growth factors (VEGF), Aflibercept and Ranibizumab, are used for the treatment of macular degeneration. Here we examined the involvement of nitric oxide (NO), mitochondria function and of apoptosis/autophagy in their antioxidant effects in human retinal pigment epithelium cells (RPE).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom